Satoshi Ichikawa

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

Lymphoid Neoplasia, End-of-induction Pet Response, Medicine +7

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

Alexander Röth, J Nishimura, Zsolt Nagy et al. · Blood · 2020 · 122 citations · Full text

Phase I study of tirabrutinib (<scp>ONO</scp>‐4059/<scp>GS</scp>‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan

Wataru Munakata, Kiyoshi Ando, Kiyohiko Hatake et al. · Cancer Science · 2019 · 49 citations · Full text

Interventional radiologic treatment for idiopathic portal hypertension

Shozo Hirota, Satoshi Ichikawa, Shinichi Matsumoto et al. · CardioVascular and Interventional Radiology · 1999 · 43 citations

Hepatology, Interventional Radiologic Treatment, Portal Hypertension +7

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study

Jun Ho Jang, Yoshiaki Tomiyama, Kôji Miyazaki et al. · British Journal of Haematology · 2020 · 36 citations · Full text